FeetMe, a medical device company that produces smart medical wearables and digital health services to improve mobility, today announced two key hires to reinforce its management team: Spencer Jacobs as Chief Commercial Officer and Olivier Simon as Chief Medical Officer. These hires come with the latest fundraise in July 2019 and the acceleration of its commercial activities in clinical trials for pharmaceutical industry and healthcare services for hospitals and rehabilitation facilities worldwide.
FeetMe announces two New Senior Leadership appointments to deliver its data driven pharma grade gait analysis platform and support its growth.
20 January 2020
FeetMe the leading provider of real-world setting gait assessment and rehabilitation solutions announces the closing of a Series A round to develop new digital health services and accelerate its commercial activities
16 September 2019
FeetMe, a medical device company that produces smart medical wearables and digital health services to improve mobility, today announced it has raised € 9.4 million in Series A funding. The investment round was led by LBO France, with additional investment from existing investors Kurma Diagnostics, the fund Paris Saclay seed fund, Idinvest Partners, Seventure and SOSV.
Novartis and FeetMe partner to develop templates that measure the progression of multiple sclerosis
26 November 2018
FeetMe gets $2.3M for smart, connected insoles
05 October 2017
FeetMe, a medical device company that produces smart and connectedinsoles for improved running, walking and gait analysis, today announced it has raised € 1.95 million in seed funding.
The investment round was led by Kurma Diagnostics, with additional investment from the new Paris Saclay seed fund, Idinvest Partners, Seventure and SOSV (a current shareholder of FeetMe).